Protective Effect of Galantamine against Doxorubicin-Induced Neurotoxicity

Background and aims: Doxorubicin (DOX) causes cognitive impairment (chemobrain) in patients with cancer. While DOX damages the cholinergic system, few studies have focused on the protective effects of cholinergic function on chemobrain. The acetylcholinesterase inhibitor galantamine (GAL) demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsikhan, Rawan S., Aldubayan, Maha A., Almami, Ibtesam S., Alhowail, Ahmad H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296141/
https://www.ncbi.nlm.nih.gov/pubmed/37371449
http://dx.doi.org/10.3390/brainsci13060971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296141/
https://www.ncbi.nlm.nih.gov/pubmed/37371449
http://dx.doi.org/10.3390/brainsci13060971

Ejemplares similares